Toward Development of Epigenetic Drugs for Central Nervous System Disorders: Modulating neuroplasticityviaH3K4 Methylation

Psychiatry and Clinical Neurosciences - United Kingdom
doi 10.1111/pcn.12426
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Anxiety Disorders in Acute Central Nervous System Infections

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2020English

The Role of Microbiome in Central Nervous System Disorders

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2014English

Improving and Accelerating Drug Development for Nervous System Disorders

Neuron
Neuroscience
2014English

Neurosteroid Regulation of Central Nervous System Development

Pharmacology and Therapeutics
Pharmacology
2007English

Cell Therapy for Central Nervous System Disorders: Current Obstacles to Progress

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2019English

Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

Drugs Acting on Central Nervous System (CNS) Targets as Leads for Non-CNS Targets

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2014English

HIV-1 Gp120 and Drugs of Abuse: Interactions in the Central Nervous System

Current HIV Research
VirologyInfectious Diseases
2012English

Development of Drug Delivery System for Treatment of Central Nervous System Diseases Targeting Tight Junctions

Drug Delivery System
Pharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy